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Abstract
Altered metabolism is an important feature of many epileptic syndromes but has not been reported in Dravet
syndrome (DS), a catastrophic childhood epilepsy associated with mutations in a voltage-activated sodium
channel, Nav1.1 (SCN1A). To address this, we developed novel methodology to assess real-time changes in
bioenergetics in zebrafish larvae between 4 and 6 d postfertilization (dpf). Baseline and 4-aminopyridine (4-AP)
stimulated glycolytic flux and mitochondrial respiration were simultaneously assessed using a Seahorse Biosci-
ences extracellular flux analyzer. Scn1Lab mutant zebrafish showed a decrease in baseline glycolytic rate and
oxygen consumption rate (OCR) compared to controls. A ketogenic diet formulation rescued mutant zebrafish
metabolism to control levels. Increasing neuronal excitability with 4-AP resulted in an immediate increase in
glycolytic rates in wild-type zebrafish, whereas mitochondrial OCR increased slightly and quickly recovered to
baseline values. In contrast, scn1Lab mutant zebrafish showed a significantly slower and exaggerated increase
of both glycolytic rates and OCR after 4-AP. The underlying mechanism of decreased baseline OCR in scn1Lab
mutants was not because of altered mitochondrial DNA content or dysfunction of enzymes in the electron
transport chain or tricarboxylic acid cycle. Examination of glucose metabolism using a PCR array identified five
glycolytic genes that were downregulated in scn1Lab mutant zebrafish. Our findings in scn1Lab mutant zebrafish
suggest that glucose and mitochondrial hypometabolism contribute to the pathophysiology of DS.
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Introduction
Glycolysis and mitochondrial oxidative phosphorylation
are key energy producing pathways in the brain. These
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Significance Statement
These studies demonstrate that metabolism can be studied in zebrafish, and that this novel approach can
be used: (1) to evaluate chemoconvulsant or genetic zebrafish models of epilepsy, or (2) in metabolism-
based drug screening efforts to identify compounds that modulate glycolysis or mitochondrial function. As
more models of epilepsy become available, the array of techniques demonstrated here can be used to
rapidly characterize metabolic contributions to disease states.
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metabolic pathways may play a role in the control of
seizures and epileptogenesis (Rowley et al., 2015). For
example, glycolytic rates are acutely increased during
ictal activity (Stafstrom et al., 2008) and ictal hypermetab-
olism in human epileptic foci is followed by interictal
hypometabolism, probably resulting from a decreased
mitochondrial bioenergetic capacity (Chugani et al., 1994;
Lee et al., 2012). Hypometabolism associated with sei-
zures may reflect glucose transport abnormalities or de-
fects in electron transport chain (ETC) enzymes (Tenney
et al., 2014). Seizures are also associated with an imbal-
ance in ATP levels (Grisar, 1984) and represent a common
symptom in patients with mitochondrial disease (Wallace
et al., 1988; Mecocci et al., 1993; Liang et al., 2012).
Although altered metabolism may be a feature of ac-
quired and/or focal epilepsies, it has not been systemat-
ically investigated in any genetic form of epilepsy. Dravet
syndrome (DS) is one example of a severe genetic epi-
lepsy most commonly associated with de novo mutations
in a brain-specific voltage-activated sodium channel
(SCN1A). DS children exhibit significant developmental
delays, cognitive deficits, behavioral disturbances, and
increased risk of sudden unexpected death in epilepsy
(SUDEP; Dravet, 2011). Two types of observations sug-
gest that metabolic dysfunction may be occurring in DS.
First, mitochondrial defects in muscle biopsies have been
reported in patients. Second, some DS children respond
positively to treatment with ketogenic diets (KDs; Cara-
ballo, 2011). Although numerous mechanisms may un-
derlie the efficacy of KDs (Gano et al., 2014), these
observations suggest that energy metabolism is not well
studied in DS, or any form of genetic epilepsy. Here we
developed novel techniques to show, for the first time,
that glycolysis and mitochondrial respiration are abnormal
in a zebrafish model of DS and its rescue by a form of a
KD. Moreover, altered metabolism in scn1Lab mutants
was accompanied by downregulation of several glycolytic
genes rather than defects in select mitochondrial enzyme
activities.
Materials and Methods
Animal care
Scn1Lab mutant zebrafish were obtained from the
Baraban laboratory at the University of California San
Francisco (UCSF) and bred in the University of Colorado
Anschutz Medical Campus (UCD) zebrafish core facility.
When obtained from UCSF, eggs were shipped overnight
and immediately placed in a 28.5°C incubator upon ar-
rival. Zebrafish larvae were maintained in “embryo me-
dium” consisting of 0.03% Instant Ocean (Aquarium
Systems) in deionized water containing 0.2 ppm methyl-
ene blue as a fungicide with no additional glucose ana-
pleurotic substrates added. Homozygous mutants (sorted
based on pigmentation) and age-matched sibling larvae
were used at 4–6 d postfertilization (dpf). Pentylenetetra-
zole (PTZ; Sigma-Aldrich) was dissolved in embryo me-
dium, pH balanced to 7.4, and bath applied. KD water
was prepared by sonication of 200 M palmitate (Sigma-
Aldrich) and laurate (Sigma-Aldrich) in embryo media con-
taining 100 M phosphatidyl choline (Sigma-Aldrich) and
bath applied (Taylor et al., 2004).
Metabolic measurements
Glycolysis and mitochondrial respiration rates were si-
multaneously measured in live zebrafish in an XF24 or
XF24e analyzer (Seahorse Bioscience). One fish was
loaded per well of a 24-well islet plate and mesh screen
placed to hold the zebrafish in place. 4-AP (Sigma-
Aldrich) was prepared in embryo medium at a stock con-
centration of 40 mM and pH balanced to 7.4. 4-AP was
injected by the XF24 analyzer at a final concentration of
4 mM.
Behavioral seizure analysis
Zebrafish were placed individually in 96-well Falcon
culture dishes. Each well contained75 l embryo media
and one 5 dpf WT zebrafish larvae. Swim behavior was
monitored in a DanioVision system, as described previ-
ously in the literature (Baraban et al., 2013). Recording
sessions (2 min) were analyzed off-line and scored for
seizure stage (Baraban et al., 2005) by an investigator
blind to the status of the fish.
Mitochondrial copy number
Relative mitochondrial copy number was determined by
real-time PCR (Hunter et al., 2010; Artuso et al., 2012).
DNA was extracted from individual fish using the DNeasy
Blood and Tissue Kit (Qiagen) following the manufacturer-
supplied instructions. A short section of mitochondrial
DNA was amplified using Power SYBR green (Forward:
5=-CAAACACAAGCCTCGCCTGTTTAC-3=; Reverse: 5=-
CACTGACTTGATGGGGGAGACAGT-3=). This was nor-
malized to the nuclear gene polg1 (Forward: 5=-GAGAGC
GTCTATAAGGAGTAC-3=; Reverse: 5=- GAGCTCATCAGA
AACAGGACT-3=). Primers were ordered from Integrated
DNA Technologies (Coralville). Fish were exposed to 4-AP
for 1 h.
Enzyme assays
Activity of complexes I–IV was determined from total
protein isolates from 25 to 30 pooled zebrafish embryos at
4–6 dpf. Total protein was isolated by resuspending ze-
brafish in PBS with 0.01% Triton-X and protease inhibi-
tors followed by probe sonication at 30% intensity for
three pulses of 5 s each. Lysate was centrifuged at 10,000
rpm for 5 min to remove insoluble material. Total protein
concentration was determined by Bradford assay. Com-
plex activity was determined by UV spectrophotometry
(Ma et al., 2011). Complex I was determined by the oxi-
dation of NADH at 340 nm. The assay solution consisted
of 25 mM potassium phosphate, 5 mM MgCl2, 2 mM KCN,
2.5 mg/ml BSA, 0.13 mM NADH, 2 ug/ml antimycin A, and
65 M ubiquinone1 equilibrated to 30°C. Forty micro-
grams of total protein was added and activity measured
for 5 min. Nonspecific activity was determined by addition
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of 2 g/ml of rotenone prior to protein addition. Complex
II was determined by reduction of dichlorophenol indo-
phenols at 600 nm. The assay solution consisted of 25 mM
KPO4, 5 mM MgCl2, 2 mM KCN, 20 mM sodium succinate,
50 M dichlorophenol indophenol, 2 g/ml rotenone, and
2 g/ml antimycin A. After equilibrating to 30°C, 40 g of
total protein was added along with 65 M ubiquinone1 to
start the reaction. Activity was determined between 3 and
5 min. Complex III was determined by the reduction of
cytochrome C at 550 nm. The assay solution consisted of
50 mM KPO4, 1 mM N-dodecyl--D-maltoside, 2 mM KCN,
and 20 mM NADH at 30°C. Forty micrograms of total
protein was added along with 100 M of reduced decyl-
benzylquinone and 40 M oxidized cytochrome C to start
the reaction. Activity was measured for 3 min. Complex IV
was determined by oxidation of cytochrome C at 550 nm.
The assay solution consisted of 20 mM KPO4 and 0.45 mM
N-dodecyl--D-maltoside equilibrated to 30°C. Forty mi-
crograms of total protein and reduced cytochrome C was
added to a final concentration of 15 M and activity
measured for 3 mins.
Activity of select enzymes of the tricarboxylic acid (TCA)
cycle, aconitase, fumarase, and malate dehydrogenase,
was determined from total protein isolates from 30 pooled
zebrafish embryos at 5 dpf. Total protein was isolated as
above with the exception of probe sonication at 30%
intensity for two pulses of 1 s each. Aconitase and fuma-
rase activity was determined by UV spectrophotometry by
following the dehydration of DL-isocitrate or L-malate, re-
spectively, at 240 nm (Patel et al., 1996). The aconitase
assay buffer consisted of 50 mM Tris HCl and 600 M
MnCl2 at pH 7.4. DL-Isocitrate substrate was added to a
final concentration of 20 mM along with 20 l of total
protein. Activity was measured for 3 min. Aconitase ac-
tivity was inhibited by addition of 0.1 mM potassium fer-
ricyanide. Fumarase assay buffer consisted of 30 mM
KH2PO4 and 100 M EDTA at a pH of 7.4. L-Malate was
added to a final concentration of 5 mM along with 20 l of
total protein. Activity was measured for 3 min. Fumarase
activity showed stereospecificity for L-malate; D-malate
was inactive. Malate dehydrogenase was determined by
measuring the decrease in absorbance at 340 nm result-
ing from oxidation of NADH. The assay buffer consisted of
0.1 M KPO4, 200 M oxaloacetic acid, and 250 M NADH,
pH 7.4. Five microliters of total protein was added and
activity measured for 5 min. All TCA cycle enzyme assays
were performed at room temperature.
Gene expression
Six to eight zebrafish were pooled for each group. RNA
was extracted by TRIzol 1 h after 4-AP treatment. cDNA
was synthesized using the RT2 First Strand Kit (SABiosci-
ences) and hybridized to the Glucose Metabolism PCR
array (SABiosciences). Array was analyzed using Applied
Biosystem 7500 Real-Time PCR System. Data was ana-
lyzed using SABiosciences’ on-line data analysis suite
(http://www.sabiosciences.com/pcrarraydataanalysis.
php). Array results were verified using specific Taqman
primers (Applied Biosystems). Fish were exposed to 4-AP
for 1 h.
Statistics
Statistical methods were performed with GraphPad
Prism v6.04 for Windows. Analyses include Holm–Sidak t
test (for baseline comparisons) and two-way one-way
ANOVA with Tukey’s multiple-comparisons test. Behav-
ioral seizure data were analyzed by Shapiro–Wilk normal-
ity test followed by Kruskal–Wallis ANOVA on Ranks with
Tukey’s multiple comparison post hoc test.
Results
To measure real-time glycolytic and mitochondrial res-
piration rates live zebrafish (4–6 dpf) were placed in an
extracellular flux analyzer (Seahorse Biosciences). The
analyzer measures extracellular acidification rate (ECAR)
and oxygen consumption rate (OCR) in a transient micro-
chamber over 3 min, representing glycolysis and mito-
chondrial respiration, respectively (Wu, 2009). Baseline
glycolysis rates in scn1Lab mutant and age-matched WT
zebrafish were 7.70  0.18 mpH/min and 13.06  0.61
mpH/min (Fig. 1A; Table 1), respectively, indicating a 41%
decrease (p  0.0001)a of baseline glycolysis. Similarly,
basal OCR was significantly decreased in scn1Labmutant
zebrafish (189.3  3.47 pmol/min) compared with WT
controls (296.5  1.929 pmol/min, p  0.0001b; Fig. 1B).
Zebrafish obtained from UCSF or bred at UCD and
metabolism measured using the Seahorse XF24 or an
updated version, the XF24e, showed similar alterations
in metabolism between scn1Lab and WT siblings (see
Fig. 6).
Scn1Lab mutant zebrafish have been reported to have
seizures very early in life, starting at about 3 dpf (Baraban
et al., 2013). To determine the consequences of increased
neuronal excitability associated with induced seizure ac-
tivity, WT zebrafish were stimulated with 4-AP and glyco-
lytic and mitochondrial respiration rates were measured
(Figs. 1A,B). 4-AP, a chemoconvulsant previously shown
to induce electrographic seizures in zebrafish (Baraban
et al., 2007), increases metabolic demand in cortical cells
and synaptosomes (Tibbs et al., 1989; Flynn et al., 2011).
Following metabolic challenge with a single, high dose of
4-AP, WT zebrafish showed increased behavioral seizure
activity (Fig. 1C,D) and 360% increase in glycolysis within
8 min. Scn1Lab mutants, which exhibit spontaneous sei-
zures at a rate of 1 ictal-like event per minute (Baraban
et al., 2013), also showed increased glycolytic rate after
4-AP stimulation albeit in a delayed manner, achieving
maximal glycolytic rates about 30 min after 4-AP addition
(Fig. 1A). In scn1Lab mutant zebrafish, glycolysis was
increased 350% from baseline to an average of 27.26 
1.12 mpH/min (p  0.0001e, Fig. 1A). Both the immediate
and delayed increase of glycolytic rates in WT and
scn1Lab mutant zebrafish were sustained for the duration
of the experiment, 48 min. After 24–32 min when scn1Lab
mutant zebrafish had maximal response to 4-AP, the
fold-change was significantly greater in scn1Lab mutant
zebrafish than that of WT zebrafish. Behavioral seizure
analysis on an independent clutch of WT larvae demon-
strated that a single concentration of 4 mM 4-AP induced
the severe convulsive seizure behavior (Stage III) at the 8
min time point in 23 of 48 larvae; circling Stage II behavior
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was noted in 25 of 48 larvae. After continuous exposure to
4-AP, seizure behavior corresponding to Stage II was
observed in the majority of zebrafish larvae (47 of 48).
Representative locomotion plots are shown for WT ze-
brafish at baseline and following exposure to 4 mM 4-AP
(Fig. 1C). Mean velocity measurements, which act as a
surrogate marker for Stage III behavior (Baraban et al.,
2013) were significantly increased at the 8 min exposure
point (Fig. 1Dc).
WT zebrafish showed a small, nonsignificant, increase
in mitochondrial respiration immediately after 4-AP stim-
ulation, which rapidly returned to baseline (Fig. 1B). How-
ever, scn1Lab mutant zebrafish showed a delayed and
gradual increase in mitochondrial respiration with maxi-
mal increase about 30 min after stimulation. Mitochondrial
respiration was increased 142% from baseline to 253.1
pmol/min in scn1Lab mutant compared with WT ze-
brafish.
These data, when plotted as OCR versus ECAR, show
a unique metabolic shift (Fig. 2A). At baseline, WT ze-
brafish are more glycolytic and oxidative than mutant
zebrafish, but both processes are in a narrow metabolic
field. Increased neuronal excitability shifts the metabolic
field toward the glycolytic direction. The mutant zebrafish
increase glycolysis and oxidative phosphorylation after
4-AP exposure to approach the metabolic state of WT
zebrafish after 4-AP. This suggests that mutant zebrafish
retain a similar metabolic capacity as WT zebrafish, or in
other words, there are no defective enzymes in the down-
stream energetic pathway. To confirm this, we assayed
three different parameters. To ensure that alterations in
mitochondrial OCR were not due to differences in mito-
chondrial content, relative mitochondrial copy number
was determined. Results demonstrate that there is no
significant difference between total mitochondrial copy
numbers between groups (p  .2056h; Fig. 2B). Next, to
determine whether OCR differences were due to altera-
tions in ETC activity, complexes I–IV were assayed in WT
and scn1Lab mutant zebrafish. No differences were ob-
served in the activity of any of the complexes (p 0.9367i;
Figure 1. Glycolytic and mitochondrial respiration rates in WT and scn1Lab mutant zebrafish at baseline and after 4-AP stimulation. A, B,
Scn1Lab mutant zebrafish have lower baseline glycolytic and mitochondrial respiration rates than WT zebrafish. 4-AP immediately
increases glycolytic andmitochondrial respiration rates inWT zebrafish.Scn1Labmutant zebrafish have a delayed response to 4-AP of30
min. Statistical analysis shows changes relative to time-matched untreated controls; points represent meansS.E.M. N  14 (WT), 16
(scn1Lab), 16 (WT4-AP), 14 (scn1Lab4-AP) individual animals, meanS.E.M. A, WT vs scn1Lab: p  0.0001a; WT vs WT4-AP, p 
2.38e-30 (8 min)o, p 8.41e-30 (16 min)p, p 3.50e-26 (24 min)q, p 3.99e-24 (32 min)r, p 2.92e-25 (40 min)s, p 1.70e-21 (48 min)t;
scn1Lab vs scn1Lab4-AP: p  3.28e-6 (8 min)u, p  1.65e-11 (16 min)v, p  1.86e-13 (24 min)w, p  3.08e-17 (32 min)x, p  2.34e-14
(40 min)y, p  3.52e-15 (48 min)z. B, WT vs scn1La: p  0.0001aa; scn1Lab versus scn1Lab4-AP: p  0.00071 (32 min)bb, p  2.20e-5
(40 min)cc, p 7.24e-5 (48 min)dd. C, D, Locomotion plots for behavioral seizure activity in WT zebrafish exposed to 4 mmM 4-AP. Bar plot
showing the mean  SEM for WT fish at baseline, 8 min after exposure to 4-AP and 48 min after exposure to 4-AP. N  48 WT fish;
Kruskal–Wallis one-way ANOVA on ranks with a post hoc Tukey test. p  0.05c,d (8 min vs baseline).
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Table 1. Statistical table
Data structure Type of test Confidence interval
a Normal distribution t test 6.78 to 3.94
b Normal distribution t test 116.0 to 98.31
c Non-normal distribution
(Shapiro–Wilk
test p  0.05)
One-way ANOVA Kruskal–Wallis
on ranks with a
post hoc Tukey test
p  0.01 ANOVA
8 min vs baseline:
p  0.05
d Non-normal distribution
(Shapiro–Wilk
test p  0.05)
One-way ANOVA Baseline vs 48 min:
p  0.05
e Normal distribution Unpaired t test 23.76 to 15.36
f Normal distribution t test with Holm–Sidak for
multiple comparisons
245.2 to 110.5
g Normal distribution t test with Holm–Sidak for
multiple comparisons
64.78 to 20.95
h Normal distribution One-way ANOVA WT vs WT4-AP 0.9128 to 0.1422
WT vs scn1Lab 0.5763 to 0.4787
WT vs scn1Lab4-AP 0.5664 to 0.4886
i Normal distribution Two-way ANOVA Complex I 148.8 to 112.6
Complex II 138.4 to 123.1
Complex III 177.9 to 83.56
Complex IV 146.6 to 114.9
j Normal distribution Two-way ANOVA Aconitase 15.04 to 45.86
Fumarase 32.52 to 28.38
Mal. Dehyd. 21.06 to 33.41
k Normal distribution t test 0.3722 to 3.172
l Normal distribution t test 65.33 to 64.27
m Normal distribution t test 236.8 to 132.0
n Normal distribution t test 1.676 to 0.3118
o Normal distribution t test with Holm–Sidak for
multiple comparisons
33.97 to 22.24
p Normal distribution t test with Holm–Sidak for
multiple comparisons
33.59 to 21.85
q Normal distribution t test with Holm–Sidak for
multiple comparisons
31.04 to 19.30
r Normal distribution t test with Holm–Sidak for
multiple comparisons
29.59 to 17.86
s Normal distribution t test with Holm–Sidak for
multiple comparisons
30.39 to 18.66
t Normal distribution t test with Holm–Sidak for
multiple comparisons
27.73 to 16.00
u Normal distribution t test with Holm–Sidak for
multiple comparisons
18.01 to 6.278
v Normal distribution t test with Holm–Sidak for
multiple comparisons
24.10 to 12.37
w Normal distribution t test with Holm–Sidak for
multiple comparisons
26.07 to 14.33
x Normal distribution t test with Holm–Sidak for
multiple comparisons
29.68 to 17.95
y Normal distribution t test with Holm–Sidak for
multiple comparisons
26.95 to 15.21
z Normal distribution t test with Holm–Sidak for
multiple comparisons
27.74 to 16.01
aa Normal distribution t test 116.0 to 98.31
bb Normal distribution t test with Holm–Sidak for
multiple comparisons
112.2 to 6.900
cc Normal distribution t test with Holm–Sidak for
multiple comparisons
128.0 to 22.77
dd Normal distribution t test with Holm–Sidak for
multiple comparisons
122.9 to 17.64
ee Normal distribution One-way ANOVA Control vs 10 M 3.649 to 7.982
Control vs 50 M 6.585 to 5.046
Control vs 100 M 4.812 to 6.819
Control vs 1 mM 6.324 to 5.307
Control vs 4 mM 7.943 to 2.825
(Continued)
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Fig. 2C). OCR may also have been decreased in scn1Lab
mutant zebrafish if the TCA cycle enzymes were inactive,
providing fewer electron donors for the ETC. Analysis of
aconitase, fumarase, and malate dehydrogenase demon-
strated no difference in enzymatic activity in WT and
mutant zebrafish (p 0.5801j; Fig. 2D). This suggests that
the primary metabolic defect may lie even further up-
stream, in glycolysis.
We therefore focused on the glycolytic pathway to un-
derstand the mechanistic basis of altered metabolism in
scn1Lab mutant zebrafish. Since the activity of oxidative
phosphorylation enzymes were unaltered in scn1Lab
mutants and previous results suggested that genes
related to metabolic processes are differentially ex-
pressed in scn1Lab mutant zebrafish (Baraban et al.,
2007), we examined gene expression changes using an
84 probe glucose metabolism microarray (Fig. 3A,B). Of
these, six genes were changed at least twofold (Fig. 3C).
Five of these six were downregulated in scn1Lab mutant
zebrafish compared with WT and included g6pca.1, pck1,
pck2, pdk2, and phkg1a. Gene expression was also ana-
lyzed 1 h after 4-AP treatment. In 4-AP stimulated ze-
brafish, four genes were changed at least twofold
compared with untreated controls (gck, pck1, pdk2, and
pdk4). PCR array results were verified using specific Taq-
man primers, which were available for pck1, pck2, and
pdk2. PCR results verified fold-changes of pck1 (2.83 
0.45), pck2 (2.36  0.45), and pdk2 (2.23  0.42) in
scn1Lab versus WT zebrafish (Fig. 3C, inset). WT ze-
brafish after 4-AP stimulation were also verified to have a
2.08  0.48-fold increase in pdk2 expression; scn1Lab
mutant zebrafish had a fold-change of 15.16  4.93 in
pdk2 expression (Fig. 3C, inset). These results suggest
that baseline decreases in ECAR and OCR in scn1Lab
mutants likely results from mutation-induced downregu-
lation of key glycolytic genes leading to an overall de-
creased flux of substrates through these pathways.
Exaggerated responses in ECAR and OCR in scn1Lab
mutants could be the result of mutation-induced upregu-
lation of key glycolytic genes (ie, pck1 and pdk2). To-
gether, alterations in glycolytic gene expression provide a
mechanistic basis for ion channel related alterations in
metabolism.
Finally, to determine whether metabolic deficits could
be rescued, we exposed developing zebrafish larvae to a
modified KD (Taylor et al., 2004) for 48 h. In scn1Lab
mutant zebrafish, baseline metabolism was raised to lev-
els similar to WT controls for both glycolysis (p 0.1043k)
and respiration (p  0.9853l; Fig. 4A). 4-AP treatment
produced a similar magnitude of increase in ECAR in both
vehicle and KD-exposed WT controls (p 0.4744m); how-
ever, the response to 4-AP was suppressed in the KD-
exposed scn1Lab mutant zebrafish to the same rates as
WT zebrafish (p  0.1294n; Fig. 4B).
Discussion
Here we demonstrate significant decreases in metabolism
in a zebrafish model of SCN1A-related epilepsy. These
mutants exhibit hyperactivity, including convulsive behav-
ior, spontaneous electrographic seizures, shortened lifes-
pan and a pharmacological profile similar to the human
condition (Baraban et al., 2013; Dinday and Baraban,
2015). We now demonstrate, using novel methodology,
that these scn1Lab mutant zebrafish, representing one
example of a genetic epilepsy, exhibit decreased gly-
colytic and mitochondrial respiration rates. Although
mitochondrial respiration has been measured in early
embryogenesis up to 48 h postfertilization (Stackley et al.,
Table 1. (Continued)
Data structure Type of test Confidence interval
ff Normal distribution One-way ANOVA Control vs 10 M 67.77 to 93.79
Control vs 50 M 62.06 to 99.49
Control vs 100 M 39.08 to 122.5
Control vs 1 mM 19.22 to 142.3
Control vs 4 mM 19.85 to 129.7
gg Normal distribution One-way ANOVA WT vs WT4-AP 0.9128 to 0.1422
WT vs scn1Lab 0.5763 to 0.4787
WT vs scn1Lab4-AP 0.5664 to 0.4886
hh Normal distribution Two-way ANOVA Complex I 148.8 to 112.6
Complex II 138.4 to 123.1
Complex III 177.9 to 83.56
Complex IV 146.6 to 114.9
ii Normal distribution Two-way ANOVA Aconitase 15.04 to 45.86
Fumarase 32.52 to 28.38
Mal. Dehyd. 21.06 to 33.41
jj Normal distribution t test 1.783 to 8.531
kk Normal distribution t test 4.128 to 2.727
ll Normal distribution t test 36.51 to 22.87
mm Normal distribution t test 98.59 to 32.08
nn Normal distribution t test 104.4 to 49.14
oo Normal distribution t test 46.07 to 30.43
pp Normal distribution t test 52.57 to 32.94
qq Normal distribution t test 35.93 to 11.69
rr Normal distribution t test 32.95 to 15.50
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2011) and cell-based (Giménez-Cassina et al., 2012) or
rodent-based (Rowley et al., 2015) systems, this is the
first time metabolism has been measured in live ze-
brafish larvae and could be useful in identifying meta-
bolic dysfunction in the growing armamentarium of
zebrafish mutants.
Hypometabolism in DS has not been extensively re-
ported in the literature. However, in a single study evalu-
ating the metabolic status of patients with DS, Craig et al.
(2012) showed comorbid electron transport defects in two
patients. One had impaired complex III activity, and the
other complex IV, in muscle biopsies from two DS pa-
tients. The etiology of the comorbidity is not entirely ob-
vious but the authors suggest an scn1a mutation is not
the only cause. Our results support these suppositions.
The scn1Labmutant zebrafish did not show any defects in
ETC complexes I–IV, suggesting respiratory chain defects
may not be inherent to DS.
The mechanism by which loss of sodium-channel func-
tion results in the constellation of symptoms observed in
DS is incompletely understood. Our results suggest a
general decrease in expression of glycolysis related
genes resulting in decreased glycolytic substrates driving
mitochondrial respiration. It is possible seizures, which
are spontaneously occurring in these mutants, induce
oxidative stress resulting in posttranslational oxidative
modification and decreased activities of complex I (Ryan
et al., 2012). Metabolic dysfunction, in particular mito-
chondrial dysfunction, has been known to have epilepsy
as a dominant or collateral feature of the phenotype (Fin-
Figure 2. Respiratory chain complex activity in WT and scn1Lab mutant zebrafish. A, ECAR and OCR from Figure 1 are replotted to
demonstrate the metabolic field and the increases in metabolic field after treatment with 4-AP. Scn1Lab mutant zebrafish increase
metabolism to approach the metabolic state of WT zebrafish after 4-AP, suggesting mutant zebrafish retain a similar metabolic
capacity as WT zebrafish; each point represents meanS.E.M. B, Relative mitochondrial copy number was determined by total
mitochondrial DNA. No significant differences were found (n  3 individual animals per group; one-way ANOVA, p  0.2056gg). C,
There is no difference in activity in complexes I–IV in WT and scn1Lab mutant zebrafish. Bars represent the mean  SEM relative to
WT activity, n  3 groups with 25–30 fish pooled per group. Two-way ANOVA, interaction, p  0.9367hh. D, There are no differences
in activity in selected TCA cycle enzymes in WT and scn1Labmutant zebrafish. Bars represent the mean SEM relative to WT activity,
n  4 groups with 30 fish per group. Two-way ANOVA, interaction, p  0.5801ii.
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Figure 3. Glucose metabolism-related gene expression in WT and scn1Lab mutant zebrafish (DRVT) at baseline and after 4-AP
stimulation. A, Heatmap demonstrating relative expression of all genes analyzed from array. B, Schematic depicting the pathways in
which up or downregulated genes are involved. Red color indicates downregulated genes in scn1Lab mutant zebrafish vs WT at
baseline. C, Graph showing the seven genes with twofold or greater changes relative to respective controls. n  6 pooled embryos
per group analyzed once. Inset, PCR verification of genes for which specific primers were available, pck2, pck4, and pdk2. N  3
groups of pooled embryos (6 per group) analyzed in triplicate, meanS.E.M.
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Figure 4. Ketogenic diet restores metabolism of scn1Labmutant zebrafish to WT levels. A, Metabolic profile of WT zebrafish is shifted
slightly to be more glycolytic after KD treatment. Mutant zebrafish increase both glycolysis and mitochondrial respiration to WT levels.
B, KD treatment reduces mutant zebrafish response to 4-AP to similar to WT levels. N  4 (WT), 4 (scn1Lab), 5 (WTKD), 5
(scn1LabKD), p  .017jj. Values or bars indicate meanS.E.M.
Figure 5. Summary diagram depicting proposed mechanism. Mechanism demonstrating changes in glycolysis and mitochondrial
respiration in scn1 mutant zebrafish at baseline (in black) and proposed action of KD (in red).
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sterer and Zarrouk Mahjoub, 2012). In addition, mito-
chondrial complex I deficiency has been observed in
human and experimental temporal lobe epilepsy (Kunz
et al., 2000). Whether the presence of seizures alone
explains the metabolic deficits is unclear and needs
further exploration.
Interestingly and consistent with a metabolic defect,
KDs have shown efficacy in controlling seizures in some
DS patients (Caraballo, 2011) and the scn1Lab mutant
zebrafish used here (Baraban et al., 2013). We now show
that a KD also improves the metabolic state of scn1Lab
mutant zebrafish to WT levels. One potential mechanism
of action is that the KD alters expression of glucose-
related metabolism genes in scn1Lab mutant zebrafish to
WT levels. However, this seems unlikely because altera-
tion of the genes reported here, and others, by KD has not
been reported in the literature. Murata et al. (2013) fed WT
and Fgf21 (fibroblast growth factor) knockout mice KD
and showed no difference in pck expression, or glucose-
6-phosphatase and PPARγ coactivator-1, compared
with normal diet. Jornayvaz et al. (2010) showed similar
results in KD fed mice for pck, glucose-6-phosphatase,
and pyruvate carboxylase compared to control diet. How-
ever, a more likely mechanism is that a KD alters the fuels
available for glycolysis and oxidative phosphorylation to
use. Impairment of mitochondrial bioenergetics capacity
can critically affect apoptosis, neuronal excitability, and
seizure susceptibility (Gano et al., 2014). Ketone bodies
can decrease the spontaneous firing of GABAergic neu-
rons, dependent on KATP channels (Ma et al., 2007) and
given the deficits in interneuron function thought to be
associated with scn1a mutation this could be a direct site
of action.
4-AP is a potassium channel blocker that is commonly
used to elicit seizures in animal models, including larval
zebrafish (Baraban et al., 2007). Here, we demonstrate
that WT zebrafish respond to 4-AP by immediately in-
creasing glycolysis but not mitochondrial respiration
corresponding with severe behavioral seizures. The met-
abolic alteration is reminiscent of ictal hypermetabolism
(Stafstrom et al., 2008) and it is interesting to note that
scn1Lab mutants have delayed increases in glycolysis
and mitochondrial respiration after a 4-AP challenge. We
also report a significant downregulation of phosphoenol-
pyruvate carboxykinases (pck1 and pck2) and pyruvate
dehydrogenase kinase (pdk2) in scn1Lab mutant, genes
Figure 6.Metabolic differences in WT and scn1labmutant zebrafish are reproducible when grown in a separate facility, as well as with
different instrumentation. All zebrafish in this figure were bred and grown at UCD. Using the same instrumentation as Figures 1 and
4 (XF24) the baseline differences are recapitulated in zebrafish grown at UCSF. The newer model of extracellular flux analysis (XF24e)
is more sensitive and thus has higher baseline values for both glycolysis and mitochondrial respiration. A, B, Absolute baseline
differences in glycolysis and respiration are recapitulated in both the XF24 and newer XF24e. A, XF24, p  .000kk; XF24e, p  .00ll;
B, XF24, p .00mm; XF24e, p .00nn. C, D, Although the XF24e is more sensitive, the relative differences in glycolysis and respiration
are similar in both the XF24 and XF24e. C, XF24, p  .00oo; XF24e, p  .00pp. D, XF24, p  .0002qq; XF24e, p  .0001rr. Bars
represent meanS.E.M.
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important in gluconeogenesis, glycogenolysis, and regu-
lation of pyruvate dehydrogenase. Specifically, pck is
responsible for converting oxaloacetate in to phosphoenol-
pyruvate, a glycolysis intermediary and its loss would result
in less intermediates and less glycolytic flux. Pdk2 is a gene
responsible for inhibition of pyruvate dehydrogenase, which
converts pyruvate to acetyl CoA. Decreased pdk2 would
result in increased pyruvate dehydrogenase activity and less
pyruvate and lactate. This could explain the lower ECAR
observed here (Sun et al., 2011). It may appear that in-
creased pyruvate dehydrogenase would result in increased
respiration in scn1Lab mutant zebrafish. However, because
there are fewer intermediates, and less flux through gly-
colysis, it is reasonable that the overall respiration rate
is reduced in scn1Lab mutant zebrafish. In WT ze-
brafish, the increase in pdk2 would increase inhibition of
pyruvate dehydrogenase and subsequently lead to in-
creases in glycolytic metabolites pyruvate and lactate,
suggesting a mechanism for increased glycolysis.
Overall, our results suggest a metabolic impairment con-
comitant with a sodium channel mutation in DS, likely due to
glycolysis gene-expression changes, and reversible by the
KD (Fig. 5). We demonstrate this with a novel technique to
assess ECAR andOCR in live zebrafish and propose that the
metabolic impairment in scn1Labmutant zebrafish may be
due to changes in gene expression related to glucose
metabolism (Fig. 3B). This approach was applied here
to one genetic model of epilepsy, but opens new ave-
nues for studying metabolism in any zebrafish model or
as a means to screen compound libraries for new drugs
that would improve metabolic function.
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